How Top-Tier Pharmas Are Scaling Downstream Chromatography — Without the Risk
BOOK US TO LEARN HOW YOU CAN SCALE YOUR DOWNSTREAM PROCESS LIKE THE GLOBAL TOP-TIER PHARMAS
Chromatography is developing fast at the moment. At Peak Biotech we're front-running the development with some of the biggest pharmas in the world. At BioProcess International 2026 we would like to meet up with interest parties to share some of our results.
Book a personal meeting below and learn:
- How you can scale up your downstream process without losing performance
- How you can reduce cost without increasing risk
- How you can design your downstream
processes for increasingly complex modalities
Book our Chief Commercial Officer – Malene Linderoth – in the form below and see how the global top-tier pharmas have optimized their downstream process, reduced risk and moved from empirical development to predictable design.
100% free with no obligations. Coffee and inspiration on us!
GET TIPS TO SCALING YOUR DOWNSTREAM PROCESS (WHILE YOU REDUCE RISK)
NOT COMING TO VIENNA? (WE'D STILL LIKE TO TALK TO YOU)
ONE TOP-10 PHARMA REDUCED DOWNSTREAM DEVELOPMENT TIME BY 30%
Description. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et
ABOUT MALENE
Malene has spent 30 years at companies like Novo Nordisk and GE Healthcare before joining Peak Biotech as CCO. She works directly with the world's leading pharmas on chromatography scale-up.
